As President, Drug Safety Solutions, and a member of Bioclinica’s executive leadership team, Humaira Qureshi leads the strategic planning and execution of our global drug safety and pharmacovigilance (PV) business. In addition to working in close collaboration with our global PV clients, Humaira oversees all program operational, commercial, and global resourcing aspects. She brings to the role over 20 years experience in clinical and post marketing safety; both strategic and operational. Humaira has demonstrated success in delivery and implementation of PV operational solutions for several top ten global pharmaceutical companies. Prior to joining Bioclinica in 2018, Humaira established and led the global pharmacovigilance business for a London-based company. During her nine years there she demonstrated exceptional customer service management and global resource management skills, delivering numerous large-scale PV engagements. Humaira has participated on a number of Global PV forums focusing on technology, sourcing and process enablement. Humaira is frequently invited to lecture and has presented on a range of PV topics before thousands at industry and academic events in the US, EU, and Asia. Humaira has a Bachelor’s degree in Medicinal Biochemistry from Royal Holloway, University of London.